The estimated Net Worth of Joseph P Errico is at least 18.4 百万$ dollars as of 13 December 2022. Mr. Errico owns over 100,000 units of ElectroCore Inc stock worth over 16,349,046$ and over the last 6 years he sold ECOR stock worth over 535,592$. In addition, he makes 1,467,120$ as Director at ElectroCore Inc.
Sign up
Mr. Errico ECOR stock SEC Form 4 insiders trading
Joseph has made over 13 trades of the ElectroCore Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 100,000 units of ECOR stock worth 33,000$ on 13 December 2022.
The largest trade he's ever made was buying 100,000 units of ElectroCore Inc stock on 13 December 2022 worth over 33,000$. On average, Joseph trades about 59,375 units every 89 days since 2019. As of 13 December 2022 he still owns at least 2,724,841 units of ElectroCore Inc stock.
You can see the complete history of Mr. Errico stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joseph Errico biography
Joseph P. Errico J.D. serves as Director of the Company. He served as the Company’s Chief Science and Strategy Officer from July 2016 to June 2019, and previously served as the Company’s Chief Executive Officer from January 2010 to July 2016. Mr. Errico has also served as a member of the Board since 2005, when he co-founded the Company with Thomas J. Errico, M.D., and Dr. Peter S. Staats, M.D., and as chairman of the Board from March 2013 until June 2018. Prior to founding the Company, Mr. Errico served as the General Manager of the Motion Preservation Unit of Stryker Spine, a Division of Stryker Corporation, from August 2004 through December 2007. Prior to that, Mr. Errico co-founded and served as the Chief Executive Officer and director for Spinecore, Inc., from September 2001 through August 2004, when that company was sold to Stryker Corporation. Mr. Errico received his B.S. in Aeronautical Engineering from the Massachusetts Institute of Technology, his M.S. in Mechanical Engineering and Materials Science from Duke University School of Engineering and his J.D. from Duke University School of Law. Mr. Errico also serves as the Managing Member of Core Ventures II, LLC and certain affiliated entities with an equity interest in the Company. The Board believes that Mr. Errico’s extensive senior management experience in innovative healthcare technology companies, and his extensive knowledge and contributions to the Company’s intellectual property, products, business, and the science of VNS, qualifies him to serve on the Board.
What is the salary of Joseph Errico?
As the Director of ElectroCore Inc, the total compensation of Joseph Errico at ElectroCore Inc is 1,467,120$. There are 1 executives at ElectroCore Inc getting paid more, with Daniel Goldberger having the highest compensation of 1,789,430$.
How old is Joseph Errico?
Joseph Errico is 51, he's been the Director of ElectroCore Inc since 2019. There are 17 older and no younger executives at ElectroCore Inc. The oldest executive at ElectroCore Inc is Peter Cuneo, 76, who is the Independent Director.
What's Joseph Errico's mailing address?
Joseph's mailing address filed with the SEC is 200 FORGE WAY, SUITE 205, , ROCKAWAY, NJ, 07866.
Insiders trading at ElectroCore Inc
Over the last 6 years, insiders at ElectroCore Inc have traded over 541,551$ worth of ElectroCore Inc stock and bought 3,996,513 units worth 5,852,816$ . The most active insiders traders include James L L Tullis、Joseph P Errico、Thomas J. Errico. On average, ElectroCore Inc executives and independent directors trade stock every 38 days with the average trade being worth of 422,718$. The most recent stock trade was executed by Thomas J. Errico on 15 August 2024, trading 5,000 units of ECOR stock currently worth 30,600$.
What does ElectroCore Inc do?
electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.
What does ElectroCore Inc's logo look like?
Complete history of Mr. Errico stock trades at ElectroCore Inc
ElectroCore Inc executives and stock owners
ElectroCore Inc executives and other stock owners filed with the SEC include:
-
Daniel Goldberger,
Chief Executive Officer, Director -
Joseph Errico,
Director -
Brian Posner,
Chief Financial Officer -
Daniel S. Goldberger,
CEO & Director -
Brian M. Posner,
CFO & Corp. Sec. -
Joseph P. Errico,
Co-Founder, Principal Investor & Director -
Hans Vitzthum,
Investor Relations -
Thomas Patton,
Independent Director -
Stephen Ondra,
Independent Director -
Trevor Moody,
Independent Director -
John Gandolfo,
Independent Director -
Thomas Errico,
Independent Director -
Peter Cuneo,
Independent Director -
Sylvester Steele,
Vice President, General Manager of the Government Channels Business Unit -
Eric Liebler,
Senior Vice President - Neurology -
Mike Romaniw,
Executive Vice President - Systems & Operations -
Michael Atieh,
Independent Chairman of the Board -
Dr. Peter S. Staats M.B.A., M.D.,
Chief Medical Officer -
Eric J. Liebler,
Sr. VP of Neurology -
Dr. Peter S. Staats,
Chief Medical Officer -
Carrie Kochek,
Sr. Director of HR -
Iain Strickland Ph.D.,
VP of Global Sales & Strategy -
Jackie Dorsky,
VP of Marketing -
Michael Romaniw,
Exec. VP of Systems & Operations -
Julie Ann Goldstein,
Director -
James L L Tullis,
Director -
Nicholas Colucci,
Director -
Global Health Innovation Fu...,
10% owner -
Carrie Smith Cox,
Director -
Ventures Ii, Llc Core,
10% owner -
Francis R. Amato,
Chief Executive Officer -
Peter S. Staats,
Chief Medical Officer -
Glenn S. Vraniak,
Chief Financial Officer -
Charles Steve Theofilos,
-
Patricia Wilber,
Director